- United States
- /
- Healthtech
- /
- NasdaqGS:TBRG
Would TruBridge (NASDAQ:TBRG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We can see that TruBridge, Inc. (NASDAQ:TBRG) does use debt in its business. But should shareholders be worried about its use of debt?
When Is Debt A Problem?
Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. The first step when considering a company's debt levels is to consider its cash and debt together.
See our latest analysis for TruBridge
How Much Debt Does TruBridge Carry?
The image below, which you can click on for greater detail, shows that at September 2024 TruBridge had debt of US$176.3m, up from US$141.9m in one year. However, it does have US$8.59m in cash offsetting this, leading to net debt of about US$167.7m.
How Healthy Is TruBridge's Balance Sheet?
The latest balance sheet data shows that TruBridge had liabilities of US$51.0m due within a year, and liabilities of US$177.9m falling due after that. On the other hand, it had cash of US$8.59m and US$61.8m worth of receivables due within a year. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$158.5m.
TruBridge has a market capitalization of US$381.9m, so it could very likely raise cash to ameliorate its balance sheet, if the need arose. But it's clear that we should definitely closely examine whether it can manage its debt without dilution. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately the future profitability of the business will decide if TruBridge can strengthen its balance sheet over time. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.
Over 12 months, TruBridge saw its revenue hold pretty steady, and it did not report positive earnings before interest and tax. While that's not too bad, we'd prefer see growth.
Caveat Emptor
Over the last twelve months TruBridge produced an earnings before interest and tax (EBIT) loss. To be specific the EBIT loss came in at US$4.2m. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. So we think its balance sheet is a little strained, though not beyond repair. However, it doesn't help that it burned through US$10m of cash over the last year. So to be blunt we think it is risky. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Be aware that TruBridge is showing 1 warning sign in our investment analysis , you should know about...
If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.
Valuation is complex, but we're here to simplify it.
Discover if TruBridge might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:TBRG
TruBridge
Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.
Fair value with moderate growth potential.
Similar Companies
Market Insights
Weekly Picks

Is this the AI replacing marketing professionals?
Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business
The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery Â
The Infrastructure AI Cannot Be Built Without
Recently Updated Narratives
Position to be managed in the supercycle of memory but too expensive for long-term hold
QXO aims for $24B revenue by 2031 with AI-driven margin expansion (Priced for good execution)
Investing in Resilience: The Case for DXN Holdings Berhad in 2026
Popular Narratives
Nu holdings will continue to disrupt the South American banking market

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
